[LXRX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -0.63%
YoY- -31.11%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 1,130 24 37 27 7,999 9,216 25,207 -40.37%
PBT -48,397 -31,934 -23,476 -20,958 -66,611 -21,797 -42,075 2.35%
Tax 101 -1,029 96 48 958 789 6,119 -49.50%
NP -48,397 -30,905 -23,572 -20,958 -66,611 -21,797 -42,075 2.35%
Tax Rate - - - - - - - -
Total Cost 49,527 30,929 23,609 20,985 74,610 31,013 67,282 -4.97%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -4,282.92 -128,770.83 -63,708.11 -77,622.22 -832.74 -236.51 -166.92 71.65%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.20 -0.16 -0.16 -0.15 -0.63 -0.21 -0.40 -10.90%
EPS Diluted -0.20 -0.16 -0.16 -0.15 -0.63 -0.21 -0.40 -10.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.